Article info

Original research
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)

Authors

  1. Correspondence to Dr Richard J Aspinall, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY, UK; r.j.aspinall{at}doctors.org.uk
View Full Text

Citation

Aspinall RJ, Hudson M, Ryder SD, et al
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)

Publication history

  • Received May 18, 2022
  • Accepted October 2, 2022
  • First published November 10, 2022.
Online issue publication 
January 23, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.